Should we treat HER, too?

Journal of clinical oncology : official journal of the American Society of Clinical Oncology ·Vol. 14 ·No. 3 ·1996-03-00 ·Pages 697-9

Hayes DF

Abstract

暂无摘要

MeSH Terms

Antibodies, Monoclonal/therapeutic use Breast Neoplasms/chemistry,drug therapy,genetics,therapy Clinical Trials, Phase II as Topic Female Genes, erbB-2 Humans Receptor, ErbB-2/antagonists & inhibitors,immunology,metabolism

Chemicals

Antibodies, Monoclonal Receptor, ErbB-2

Authors & Affiliations

1 authors, click to expand affiliations / ORCID

Hayes D F

Article Info

Journal

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Abbr.

J Clin Oncol

ISSN

0732-183X

DOI

10.1200/JCO.1996.14.3.697

Published

1996-03-00

Pages

697-9

Language

English

Region

United States

NLM ID

8309333

Subset

Corrections

CommentOn

PMID: 8622019

External Links

PubMed source DOI: 10.1200/JCO.1996.14.3.697 View journal details

Analysis Services

Should we treat HER, too?

Contact

WeChat Official Account